Total Valuation
Nika Pharmaceuticals Inc has a market cap or net worth of $222.61M. The enterprise value is $534.55M.
Market Cap$222.61M
Enterprise Value$534.55M
Share Statistics
Nika Pharmaceuticals Inc has 1,048,549,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,048,549,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nika Pharmaceuticals Inc’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is 25.67%.
Return on Equity (ROE)0.26
Return on Assets (ROA)-3.64
Return on Invested Capital (ROIC)25.67%
Return on Capital Employed (ROCE)0.26
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Nika Pharmaceuticals Inc is ―. Nika Pharmaceuticals Inc’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio-1.34K
Price to Fair Value-1.34K
Price to FCF-5.00K
Price to Operating Cash Flow-12.77K
PEG Ratio0.00
Income Statement
In the last 12 months, Nika Pharmaceuticals Inc had revenue of 0.00 and earned -76.40K in profits. Earnings per share was >-0.01.
Revenue0.00
Gross Profit0.00
Operating Income-76.40K
Pretax Income-76.40K
Net Income-76.40K
EBITDA-76.40K
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -80.07K and capital expenditures 0.00, giving a free cash flow of -80.07K billion.
Operating Cash Flow-80.07K
Free Cash Flow-80.07K
Free Cash Flow per Share>-0.01
Dividends & Yields
Nika Pharmaceuticals Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.06
52-Week Price Change-46.32%
50-Day Moving Average0.52
200-Day Moving Average0.48
Relative Strength Index (RSI)42.59
Average Volume (3m)1.08K
Important Dates
Nika Pharmaceuticals Inc upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Nika Pharmaceuticals Inc as a current ratio of 0.07, with Debt / Equity ratio of 0.00%
Current Ratio0.07
Quick Ratio0.07
Debt to Market Cap0.00
Net Debt to EBITDA0.02
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Nika Pharmaceuticals Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Nika Pharmaceuticals Inc EV to EBITDA ratio is -5.21K, with an EV/FCF ratio of -5.00K.
EV to Sales0.00
EV to EBITDA-5.21K
EV to Free Cash Flow-5.00K
EV to Operating Cash Flow-5.00K
Balance Sheet
Nika Pharmaceuticals Inc has $1.53K in cash and marketable securities with $0.00 in debt, giving a net cash position of $1.53K billion.
Cash & Marketable Securities$1.53K
Total Debt$0.00
Net Cash$1.53K
Net Cash Per Share<$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Nika Pharmaceuticals Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-100.00%
EPS Growth Forecast―